Selvi, F.R.; Longhino, D.; Lucca, G.; Baglivo, I.; Zavarella, M.A.; Laface, C.; Bruno, L.; Delfino Spiga, A.; Gamberale, S.; Fabbroni, L.;
et al. Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics. Biomedicines 2025, 13, 2096.
https://doi.org/10.3390/biomedicines13092096
AMA Style
Selvi FR, Longhino D, Lucca G, Baglivo I, Zavarella MA, Laface C, Bruno L, Delfino Spiga A, Gamberale S, Fabbroni L,
et al. Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics. Biomedicines. 2025; 13(9):2096.
https://doi.org/10.3390/biomedicines13092096
Chicago/Turabian Style
Selvi, Fabio Romano, David Longhino, Gabriele Lucca, Ilaria Baglivo, Maria Antonietta Zavarella, Chiara Laface, Laura Bruno, Arianna Delfino Spiga, Sara Gamberale, Ludovica Fabbroni,
and et al. 2025. "Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics" Biomedicines 13, no. 9: 2096.
https://doi.org/10.3390/biomedicines13092096
APA Style
Selvi, F. R., Longhino, D., Lucca, G., Baglivo, I., Zavarella, M. A., Laface, C., Bruno, L., Delfino Spiga, A., Gamberale, S., Fabbroni, L., Rizzi, A., Aruanno, A., Curci, M., Buonomo, A., Colantuono, S., Viola, M., Ianiro, G., Gasbarrini, A., & Caruso, C.
(2025). Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics. Biomedicines, 13(9), 2096.
https://doi.org/10.3390/biomedicines13092096
